Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Azenta price target lowered to $94 from $106 at B. Riley » 07:42
05/17/22
05/17
07:42
05/17/22
07:42
AZTA

Azenta

$74.56 /

-0.485 (-0.65%)

B. Riley analyst Yuan Zhi…

B. Riley analyst Yuan Zhi lowered the firm's price target on Azenta to $94 from $106 and keeps a Buy rating on the shares. The recent stock movement in the healthcare service an technology sector and the trading volume in the past week gives confidence in the "bottom-forming of these growth-oriented stocks," Zhi tells investors in a research note. The analyst remains a buyer of the life sciences services providers that maintain "strong growth."

ShowHide Related Items >><<
AZTA Azenta
$74.56 /

-0.485 (-0.65%)

AZTA Azenta
$74.56 /

-0.485 (-0.65%)

05/10/22 Needham
Azenta price target lowered to $94 from $115 at Needham
03/31/22 B. Riley
Azenta resumed with a Buy at B. Riley
03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
AZTA Azenta
$74.56 /

-0.485 (-0.65%)

AZTA Azenta
$74.56 /

-0.485 (-0.65%)

AZTA Azenta
$74.56 /

-0.485 (-0.65%)

Over a week ago
Recommendations
Azenta price target lowered to $94 from $115 at Needham » 09:13
05/10/22
05/10
09:13
05/10/22
09:13
AZTA

Azenta

$64.69 /

-6.35 (-8.94%)

Needham analyst David…

Needham analyst David Saxon lowered the firm's price target on Azenta to $94 from $115 to reflect peer multiple contraction but keeps a Buy rating on the shares. M&A is the likely next catalyst for the company, though he expects Azenta's organic underlying strength to continue as COVID-related headwinds ease, the analyst tells investors in a research note.

ShowHide Related Items >><<
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

03/31/22 B. Riley
Azenta resumed with a Buy at B. Riley
03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

Earnings
Azenta sees Q3 adjusted EPS 9c-17c, consensus 18c » 16:35
05/09/22
05/09
16:35
05/09/22
16:35
AZTA

Azenta

$64.69 /

-6.35 (-8.94%)

Sees Q3 revenue…

Sees Q3 revenue $140M-$150M, consensus $150.38M.

ShowHide Related Items >><<
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

03/31/22 B. Riley
Azenta resumed with a Buy at B. Riley
03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

Earnings
Azenta reports Q2 preliminary adjusted EPS 12c, consensus 11c » 16:34
05/09/22
05/09
16:34
05/09/22
16:34
AZTA

Azenta

$64.69 /

-6.35 (-8.94%)

Reports Q2 preliminary…

Reports Q2 preliminary revenue $146M, consensus $142.1M.

ShowHide Related Items >><<
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

03/31/22 B. Riley
Azenta resumed with a Buy at B. Riley
03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

AZTA Azenta
$64.69 /

-6.35 (-8.94%)

Over a month ago
Initiation
Azenta resumed with a Buy at B. Riley » 08:16
03/31/22
03/31
08:16
03/31/22
08:16
AZTA

Azenta

$86.03 /

-2.34 (-2.65%)

B. Riley analyst Yuan Zhi…

B. Riley analyst Yuan Zhi resumed coverage of Azenta with a Buy rating and $106 price target. The company is a global leader of cold-chain sample management solutions and genomics service providers, Zhi tells investors in a research note. The analyst says Azenta has built leading capabilities of genomics, cryostorage, automation, and informatics to accelerate drug discovery and delivery. Zhi models 2022 revenue growth of 15%, with a gross margin of 49% and adjusted EBITDA of $113M.

ShowHide Related Items >><<
AZTA Azenta
$86.03 /

-2.34 (-2.65%)

AZTA Azenta
$86.03 /

-2.34 (-2.65%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
AZTA Azenta
$86.03 /

-2.34 (-2.65%)

AZTA Azenta
$86.03 /

-2.34 (-2.65%)

AZTA Azenta
$86.03 /

-2.34 (-2.65%)

Conference/Events
KeyBanc to hold a virtual forum » 04:55
03/23/22
03/23
04:55
03/23/22
04:55
AGTI

Agiliti

$20.24 /

+0.41 (+2.07%)

, AMWL

Amwell

$3.97 /

+0.145 (+3.80%)

, ANGO

AngioDynamics

$22.71 /

-0.44 (-1.90%)

, AVNS

Avanos

$32.46 /

+0.51 (+1.60%)

, AVTR

Avantor

$34.73 /

+0.245 (+0.71%)

, AZTA

Azenta

$86.72 /

+0.19 (+0.22%)

, BLFS

BioLife Solutions

$23.18 /

+0.335 (+1.47%)

, CSTL

Castle Biosciences

$45.89 /

+2.68 (+6.20%)

, EBS

Emergent BioSolutions

$42.52 /

+1.03 (+2.48%)

, ENZ

Enzo Biochem

$3.04 /

+0.04 (+1.33%)

, EVH

Evolent Health

$31.91 /

+0.55 (+1.75%)

, ICUI

ICU Medical

$242.89 /

-4.85 (-1.96%)

, INGN

Inogen

$33.31 /

+0.1 (+0.30%)

, IVC

Invacare

$1.60 /

+0.01 (+0.63%)

, LMAT

LeMaitre

$45.32 /

+1.54 (+3.52%)

, MRVI

Maravai Lifesciences

$38.84 /

+0.34 (+0.88%)

, NXGN

NextGen Healthcare

$20.31 /

+0.15 (+0.74%)

, PINC

Premier

$35.90 /

+0.07 (+0.20%)

, TFX

Teleflex

$346.65 /

-0.61 (-0.18%)

, WST

West Pharmaceutical

$413.43 /

+0.93 (+0.23%)

, XGN

Exagen

$8.25 /

+0.21 (+2.61%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.25 /

+0.21 (+2.61%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

PINC Premier
$35.90 /

+0.07 (+0.20%)

NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

INGN Inogen
$33.31 /

+0.1 (+0.30%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

AVNS Avanos
$32.46 /

+0.51 (+1.60%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.97 /

+0.145 (+3.80%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.46 /

+0.51 (+1.60%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.73 /

+0.245 (+0.71%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.72 /

+0.19 (+0.22%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$242.89 /

-4.85 (-1.96%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.31 /

+0.1 (+0.30%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.60 /

+0.01 (+0.63%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Leerink
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Leerink
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.90 /

+0.07 (+0.20%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$346.65 /

-0.61 (-0.18%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.25 /

+0.21 (+2.61%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

PINC Premier
$35.90 /

+0.07 (+0.20%)

NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

INGN Inogen
$33.31 /

+0.1 (+0.30%)

ICUI ICU Medical
$242.89 /

-4.85 (-1.96%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

AVNS Avanos
$32.46 /

+0.51 (+1.60%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

Conference/Events
KeyBanc to hold a virtual forum » 04:55
03/22/22
03/22
04:55
03/22/22
04:55
AGTI

Agiliti

$19.82 /

+0.8 (+4.21%)

, AMWL

Amwell

$3.82 /

-0.13 (-3.29%)

, ANGO

AngioDynamics

$23.05 /

-0.91 (-3.80%)

, AVNS

Avanos

$32.09 /

-0.415 (-1.28%)

, AVTR

Avantor

$34.49 /

-0.655 (-1.86%)

, AZTA

Azenta

$86.50 /

-0.82 (-0.94%)

, BLFS

BioLife Solutions

$22.98 /

-1.63 (-6.62%)

, CSTL

Castle Biosciences

$43.62 /

-1.41 (-3.13%)

, EBS

Emergent BioSolutions

$41.42 /

-1.5 (-3.49%)

, ENZ

Enzo Biochem

$3.00 /

-0.08 (-2.60%)

, EVH

Evolent Health

$31.34 /

+0.495 (+1.60%)

, ICUI

ICU Medical

$247.68 /

+2.9 (+1.18%)

, INGN

Inogen

$33.42 /

+0.15 (+0.45%)

, IVC

Invacare

$1.59 /

-0.13 (-7.56%)

, LMAT

LeMaitre

$44.15 /

-1.91 (-4.15%)

, MRVI

Maravai Lifesciences

$38.50 /

-2.28 (-5.59%)

, NXGN

NextGen Healthcare

$20.16 /

+0.35 (+1.77%)

, PINC

Premier

$35.85 /

-0.51 (-1.40%)

, TFX

Teleflex

$349.16 /

-1.02 (-0.29%)

, WST

West Pharmaceutical

$412.49 /

-1.72 (-0.42%)

, XGN

Exagen

$8.15 /

-0.33 (-3.89%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.82 /

-0.13 (-3.29%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.09 /

-0.415 (-1.28%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.49 /

-0.655 (-1.86%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.50 /

-0.82 (-0.94%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.42 /

+0.15 (+0.45%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.59 /

-0.13 (-7.56%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Leerink
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Leerink
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.85 /

-0.51 (-1.40%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$349.16 /

-1.02 (-0.29%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

XGN Exagen
$8.15 /

-0.33 (-3.89%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
  • 23
    Mar
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

Conference/Events
KeyBanc to hold a virtual forum » 17:05
03/21/22
03/21
17:05
03/21/22
17:05
AGTI

Agiliti

$19.82 /

+0.8 (+4.21%)

, AMWL

Amwell

$3.82 /

-0.13 (-3.29%)

, ANGO

AngioDynamics

$23.05 /

-0.91 (-3.80%)

, AVNS

Avanos

$32.09 /

-0.415 (-1.28%)

, AVTR

Avantor

$34.49 /

-0.655 (-1.86%)

, AZTA

Azenta

$86.50 /

-0.82 (-0.94%)

, BLFS

BioLife Solutions

$22.98 /

-1.63 (-6.62%)

, CSTL

Castle Biosciences

$43.62 /

-1.41 (-3.13%)

, EBS

Emergent BioSolutions

$41.42 /

-1.5 (-3.49%)

, ENZ

Enzo Biochem

$3.00 /

-0.08 (-2.60%)

, EVH

Evolent Health

$31.34 /

+0.495 (+1.60%)

, ICUI

ICU Medical

$247.68 /

+2.9 (+1.18%)

, INGN

Inogen

$33.42 /

+0.15 (+0.45%)

, IVC

Invacare

$1.59 /

-0.13 (-7.56%)

, LMAT

LeMaitre

$44.15 /

-1.91 (-4.15%)

, MRVI

Maravai Lifesciences

$38.50 /

-2.28 (-5.59%)

, NXGN

NextGen Healthcare

$20.16 /

+0.35 (+1.77%)

, PINC

Premier

$35.85 /

-0.51 (-1.40%)

, TFX

Teleflex

$349.16 /

-1.02 (-0.29%)

, WST

West Pharmaceutical

$412.49 /

-1.72 (-0.42%)

, XGN

Exagen

$8.15 /

-0.33 (-3.89%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.82 /

-0.13 (-3.29%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.09 /

-0.415 (-1.28%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.49 /

-0.655 (-1.86%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.50 /

-0.82 (-0.94%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.42 /

+0.15 (+0.45%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.59 /

-0.13 (-7.56%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Leerink
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Leerink
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.85 /

-0.51 (-1.40%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$349.16 /

-1.02 (-0.29%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

XGN Exagen
$8.15 /

-0.33 (-3.89%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
  • 23
    Mar
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:57
03/21/22
03/21
09:57
03/21/22
09:57
IPG

Interpublic Group

$36.42 /

+0.38 (+1.05%)

, DUOL

Duolingo

$91.17 /

+2.09 (+2.35%)

, APD

Air Products

$237.31 /

+5.75 (+2.48%)

, CBSH

Commerce Bancshares

$72.22 /

+1.17 (+1.65%)

, IAS

Integral Ad Science

$15.47 /

+0.905 (+6.21%)

, DDL

Dingdong

$3.78 /

+0.05 (+1.34%)

, EHTH

eHealth

$12.85 /

-0.39 (-2.95%)

, BLND

Blend Labs

$6.79 /

-0.285 (-4.03%)

, AVPT

AvePoint

$5.92 /

-0.035 (-0.59%)

, AZTA

Azenta

$87.95 /

+0.63 (+0.72%)

, SI

Silvergate Capital

$144.00 /

+6.595 (+4.80%)

, UGRO

Urban-Gro

$12.80 /

+0.67 (+5.52%)

, SPTN

SpartanNash

$35.44 /

+0.685 (+1.97%)

, EFSC

Enterprise Financial

$49.27 /

-0.07 (-0.14%)

, AMZN

Amazon.com

$3,237.00 /

+8.42 (+0.26%)

, CHKP

Check Point

$136.00 /

-4.22 (-3.01%)

Institutional investors…

ShowHide Related Items >><<
UGRO Urban-Gro
$12.80 /

+0.67 (+5.52%)

SPTN SpartanNash
$35.44 /

+0.685 (+1.97%)

SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

IPG Interpublic Group
$36.42 /

+0.38 (+1.05%)

IAS Integral Ad Science
$15.47 /

+0.905 (+6.21%)

EHTH eHealth
$12.85 /

-0.39 (-2.95%)

EFSC Enterprise Financial
$49.27 /

-0.07 (-0.14%)

DUOL Duolingo
$91.17 /

+2.09 (+2.35%)

DDL Dingdong
$3.78 /

+0.05 (+1.34%)

CHKP Check Point
$136.00 /

-4.22 (-3.01%)

CBSH Commerce Bancshares
$72.22 /

+1.17 (+1.65%)

BLND Blend Labs
$6.79 /

-0.285 (-4.03%)

AZTA Azenta
$87.95 /

+0.63 (+0.72%)

AVPT AvePoint
$5.92 /

-0.035 (-0.59%)

APD Air Products
$237.31 /

+5.75 (+2.48%)

AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

IPG Interpublic Group
$36.42 /

+0.38 (+1.05%)

03/21/22 Argus
Argus upgrades Interpublic Group to Buy amid increased demand, Acxiom benefits
03/21/22 Argus
Interpublic Group upgraded to Buy from Hold at Argus
03/14/22 Barclays
Interpublic Group downgraded to Equal Weight from Overweight at Barclays
01/27/22 BofA
Interpublic Group downgraded to Underperform from Neutral at BofA
DUOL Duolingo
$91.17 /

+2.09 (+2.35%)

03/21/22 KeyBanc
KeyBanc upgrades Duolingo to Overweight with $112 price target
03/21/22 KeyBanc
Duolingo upgraded to Overweight from Sector Weight at KeyBanc
03/15/22 Evercore ISI
Duolingo, XPO Logistics added to 'Best SMID 'Core' Ideas' list at Evercore ISI
03/04/22 Evercore ISI
Duolingo removed from 'Tactical Outperform' list, target cut to $120 at Evercore
APD Air Products
$237.31 /

+5.75 (+2.48%)

03/21/22 JPMorgan
Air Products upgraded to Overweight from Neutral at JPMorgan
02/08/22 BMO Capital
Air Products downgraded to Market Perform from Outperform at BMO Capital
02/07/22 Cowen
Air Products price target lowered to $345 from $365 at Cowen
02/07/22 Wells Fargo
Air Products price target lowered to $325 from $335 at Wells Fargo
CBSH Commerce Bancshares
$72.22 /

+1.17 (+1.65%)

03/21/22 Wells Fargo
Wells Fargo upgrades Commerce Bancshares to Equal Weight, ups target to $70
03/21/22 Wells Fargo
Commerce Bancshares upgraded to Equal Weight from Underweight at Wells Fargo
10/11/21 Jefferies
Commerce Bancshares price target lowered to $67 from $75 at Jefferies
04/16/21 BofA
Commerce Bancshares downgraded to Underperform from Neutral at BofA
IAS Integral Ad Science
$15.47 /

+0.905 (+6.21%)

03/21/22 Raymond James
Integral Ad Science upgraded at Raymond James amid 'unjustified' selloff
03/21/22 Raymond James
Integral Ad Science upgraded to Strong Buy from Outperform at Raymond James
03/17/22 Barclays
Barclays says Meta opening up feed positive for DoubleVerify, Integral Ad
03/04/22 Barclays
Integral Ad Science price target lowered to $20 from $23 at Barclays
DDL Dingdong
$3.78 /

+0.05 (+1.34%)

03/21/22 Morgan Stanley
Dingdong downgraded to Underweight from Overweight at Morgan Stanley
03/14/22 JPMorgan
JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
03/14/22 JPMorgan
Dingdong price target lowered to $2.50 from $21 at JPMorgan
11/19/21 JPMorgan
Dingdong initiated with an Underweight at JPMorgan
EHTH eHealth
$12.85 /

-0.39 (-2.95%)

03/21/22 Citi
eHealth downgraded to Neutral from Buy at Citi
03/03/22 Credit Suisse
eHealth price target lowered to $16 from $31 at Credit Suisse
03/02/22 Craig-Hallum
eHealth price target lowered to $15 from $33 at Craig-Hallum
03/02/22 Truist
eHealth downgraded to Hold from Buy at Truist
BLND Blend Labs
$6.79 /

-0.285 (-4.03%)

03/21/22 Truist
Truist cuts Blend Labs to Hold on lower mortgage applications, stagflation risk
03/21/22 Truist
Blend Labs downgraded to Hold from Buy at Truist
02/14/22 Keefe Bruyette
Blend Labs initiated with a Market Perform at Keefe Bruyette
01/25/22 KeyBanc
Blend Labs price target lowered to $10 from $16 at KeyBanc
AVPT AvePoint
$5.92 /

-0.035 (-0.59%)

03/21/22 Goldman Sachs
AvePoint downgraded to Neutral from Buy at Goldman Sachs
01/11/22 Cantor Fitzgerald
AvePoint initiated with an Overweight at Cantor Fitzgerald
01/11/22 Cantor Fitzgerald
AvePoint initiated with an Overweight at Cantor Fitzgerald
08/16/21 Cowen
Cowen starts 'undiscovered' AvePoint with Outperform, $14.50 target
AZTA Azenta
$87.95 /

+0.63 (+0.72%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

03/21/22 BofA
Silvergate Capital initiated with a Buy at BofA
03/17/22 B. Riley
Zions Bancorp downgraded to Neutral on valuation at B. Riley
02/01/22 JPMorgan
Silvergate Capital price target lowered to $175 from $200 at JPMorgan
01/26/22 Keefe Bruyette
Bloomberg report could weigh on Silvergate shares, says Keefe Bruyette
UGRO Urban-Gro
$12.80 /

+0.67 (+5.52%)

03/21/22 Maxim
Urban-Gro initiated with a Buy at Maxim
03/21/22 Maxim
Urban-Gro initiated with a Buy at Maxim
SPTN SpartanNash
$35.44 /

+0.685 (+1.97%)

03/21/22 CL King
SpartanNash initiated with a Neutral at CL King
11/15/21 Northcoast
SpartanNash downgraded to Neutral from Buy at Northcoast
11/12/21 Deutsche Bank
SpartanNash price target raised to $24 from $21 at Deutsche Bank
EFSC Enterprise Financial
$49.27 /

-0.07 (-0.14%)

03/21/22 Boenning & Scattergood
Enterprise Financial initiated with an Outperform at Boenning & Scattergood
AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

03/16/22 Needham
Needham says Netflix needs ads as streamers turn to news, sports
03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
03/10/22 Deutsche Bank
Amazon.com initiated with a Buy at Deutsche Bank
CHKP Check Point
$136.00 /

-4.22 (-3.01%)

03/21/22 Piper Sandler
Check Point downgraded to Underweight from Neutral at Piper Sandler
03/17/22 Deutsche Bank
Check Point price target raised to $160 from $154 at Deutsche Bank
03/10/22 Cowen
Check Point price target raised to $164 from $142 at Cowen
02/16/22 BMO Capital
Check Point upgraded to Outperform from Market Perform at BMO Capital
UGRO Urban-Gro
$12.80 /

+0.67 (+5.52%)

SPTN SpartanNash
$35.44 /

+0.685 (+1.97%)

SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

IPG Interpublic Group
$36.42 /

+0.38 (+1.05%)

IAS Integral Ad Science
$15.47 /

+0.905 (+6.21%)

EHTH eHealth
$12.85 /

-0.39 (-2.95%)

EFSC Enterprise Financial
$49.27 /

-0.07 (-0.14%)

DUOL Duolingo
$91.17 /

+2.09 (+2.35%)

CHKP Check Point
$136.00 /

-4.22 (-3.01%)

CBSH Commerce Bancshares
$72.22 /

+1.17 (+1.65%)

BLND Blend Labs
$6.79 /

-0.285 (-4.03%)

AZTA Azenta
$87.95 /

+0.63 (+0.72%)

AVPT AvePoint
$5.92 /

-0.035 (-0.59%)

APD Air Products
$237.31 /

+5.75 (+2.48%)

AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

  • 07
    Dec
  • 28
    Jul
  • 16
    Jul
  • 29
    Jun
  • 30
    Jun
SPTN SpartanNash
$35.44 /

+0.685 (+1.97%)

SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

DDL Dingdong
$3.78 /

+0.05 (+1.34%)

CHKP Check Point
$136.00 /

-4.22 (-3.01%)

AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

SPTN SpartanNash
$35.44 /

+0.685 (+1.97%)

SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

IPG Interpublic Group
$36.42 /

+0.38 (+1.05%)

EHTH eHealth
$12.85 /

-0.39 (-2.95%)

DUOL Duolingo
$91.17 /

+2.09 (+2.35%)

DDL Dingdong
$3.78 /

+0.05 (+1.34%)

CHKP Check Point
$136.00 /

-4.22 (-3.01%)

AVPT AvePoint
$5.92 /

-0.035 (-0.59%)

APD Air Products
$237.31 /

+5.75 (+2.48%)

AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

SI Silvergate Capital
$144.00 /

+6.595 (+4.80%)

BLND Blend Labs
$6.79 /

-0.285 (-4.03%)

AZTA Azenta
$87.95 /

+0.63 (+0.72%)

AVPT AvePoint
$5.92 /

-0.035 (-0.59%)

AMZN Amazon.com
$3,237.00 /

+8.42 (+0.26%)

Initiation
Azenta initiated with an Outperform at Evercore ISI » 06:39
03/21/22
03/21
06:39
03/21/22
06:39
AZTA

Azenta

$87.25 /

+2.1 (+2.47%)

Evercore ISI analyst…

Evercore ISI analyst Vijay Kumar initiated coverage of Azenta with an Outperform rating and $100 price target. With the recent sale of its semi business and the company changing its name to "Azenta" from "Brooks Automation," the company has transitioned from an "industrial/cyclical bent" to pure play life sciences with 100% of its revenues now being life sciences, said Kumar, who sees Azenta offering a "compelling" superior revenue growth outlook with 50% EPS compound annual growth rate potential.

ShowHide Related Items >><<
AZTA Azenta
$87.25 /

+2.1 (+2.47%)

AZTA Azenta
$87.25 /

+2.1 (+2.47%)

02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
AZTA Azenta
$87.25 /

+2.1 (+2.47%)

AZTA Azenta
$87.25 /

+2.1 (+2.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.